000 01649 a2200457 4500
005 20250516192509.0
264 0 _c20150814
008 201508s 0 0 eng d
022 _a1433-8726
024 7 _a10.1007/s00345-014-1240-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVallier, Cédric
245 0 0 _aExternal validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer.
_h[electronic resource]
260 _bWorld journal of urology
_cDec 2014
300 _a1573-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCohort Studies
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aHumans
650 0 4 _aLymph Node Excision
650 0 4 _aMale
650 0 4 _aNeoplasm Recurrence, Local
_xdiagnosis
650 0 4 _aNeoplasm, Residual
650 0 4 _aNeoplasms, Germ Cell and Embryonal
_xdiagnosis
650 0 4 _aPatient Selection
650 0 4 _aReproducibility of Results
650 0 4 _aRetroperitoneal Space
650 0 4 _aTesticular Neoplasms
_xdiagnosis
700 1 _aSavoie, Pierre-Henri
700 1 _aDelpero, Jean-Robert
700 1 _aBladou, Franck
700 1 _aGravis, Gwenaëlle
700 1 _aSalem, Naji
700 1 _aRossi, Dominique
700 1 _aWalz, Jochen
773 0 _tWorld journal of urology
_gvol. 32
_gno. 6
_gp. 1573-8
856 4 0 _uhttps://doi.org/10.1007/s00345-014-1240-6
_zAvailable from publisher's website
999 _c23465778
_d23465778